Cargando…
Neonatal Group B Streptococcal Disease in Otherwise Healthy Infants: Failure of Specific Neonatal Immune Responses
Only a small proportion of newborn infants exposed to a pathogenic microorganism develop overt infection. Susceptibility to infection in preterm infants and infants with known comorbidities has a likely multifactorial origin and can be often attributed to the concurrence of iatrogenic factors, envir...
Autores principales: | Borghesi, Alessandro, Stronati, Mauro, Fellay, Jacques |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5339282/ https://www.ncbi.nlm.nih.gov/pubmed/28326082 http://dx.doi.org/10.3389/fimmu.2017.00215 |
Ejemplares similares
-
Stem Cell Therapy for Neonatal Diseases Associated with Preterm Birth
por: Borghesi, Alessandro, et al.
Publicado: (2013) -
Antimicrobial therapy in neonatal intensive care unit
por: Tzialla, Chryssoula, et al.
Publicado: (2015) -
Innate Immunity of Neonates and Infants
por: Yu, Jack C., et al.
Publicado: (2018) -
Strategies for preventing group B streptococcal infections in newborns: a nation-wide survey of Italian policies
por: Tzialla, Chryssoula, et al.
Publicado: (2017) -
Bacterial and Host Determinants of Group B Streptococcal Infection of the Neonate and Infant
por: Furuta, Anna, et al.
Publicado: (2022)